ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Lewis Drugs, INC.

Official 2024 U.S. DOL Form 5500 summary for Lewis Drugs, INC. (Lewis Drugs, INC. 401(k) Plan · EIN 46-0212323 · PN 001): $56.07M net assets, 1,258 active participants, and $32.70 per $10,000 (32.70 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorLewis Drugs, INC.
Filing IdentifierLewis Drugs, INC. 401(k) Plan · EIN 46-0212323 · PN 001
Plan Category & State401(k) Defined Contribution (SD)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$56.07M
Active Participants1,258
Direct Admin Fee Rate$32.70 per $10,000 (32.70 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderMorgan Stanley
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($99,423, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI